Minaris Advanced Therapies
Overview
Minaris Advanced Therapies is a pharmaceutical company headquartered in Philadelphia, United States, founded in 2025, with approximately 501 employees.
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Minaris Advanced Therapies in our records. PharmaTek screens the full directory against live FDA enforcement data.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.